I agree that this site is using cookies. You can find further informations here.
X
Puaux, Anne-Laure
20  results:
Search for persons X
?
1

The fully synthetic MAG-Tn3 therapeutic vaccine containing ..:

Laubreton, Daphné ; Bay, Sylvie ; Sedlik, Christine...
Cancer Immunology, Immunotherapy.  65 (2016)  3 - p. 315-325 , 2016
Link: https://doi.org/10.1007/..
 
?
2

Lymphadenectomy promotes tumor growth and cancer cell disse..:

Pin, Yeo Kim ; Khoo, Karen ; Tham, Muly...
Oncotarget.  6 (2015)  42 - p. 44806-44818 , 2015
Link: https://doi.org/10.18632..
 
?
3

MEK inhibition, alone or in combination with BRAF inhibitio..:

Vella, Laura J ; Pasam, Anupama ; Dimopoulos, Nektaria...
Journal for ImmunoTherapy of Cancer.  1 (2013)  S1 - p. , 2013
Link: https://doi.org/10.1186/..
 
?
4

A Comparison of Imaging Techniques to Monitor Tumor Growth ..:

Puaux, Anne-Laure ; Ong, Lai Chun ; Jin, Yi...
International Journal of Molecular Imaging.  2011 (2011)  - p. 1-12 , 2011
Link: https://doi.org/10.1155/..
 
?
5

A simple trogocytosis-based method to detect, quantify, cha..:

Daubeuf, Sandrine ; Puaux, Anne-Laure ; Joly, Etienne.
Nature Protocols.  1 (2006)  6 - p. 2536-2542 , 2006
Link: https://doi.org/10.1038/..
 
?
6

In vivo induction of cellular and humoral immune responses ..:

Marsac, Delphine ; Puaux, Anne-Laure ; Rivière, Yves.
Immunobiology.  210 (2005)  5 - p. 305-319 , 2005
Link: https://doi.org/10.1016/..
 
?
7

Efficient priming of simian/human immunodeficiency virus (S..:

Puaux, Anne-Laure ; Marsac, Delphine ; Prost, Stéphane...
Vaccine.  22 (2004)  27-28 - p. 3535-3545 , 2004
Link: https://doi.org/10.1016/..
 
?
8

New gene-based approaches for an AIDS vaccine:

Puaux, Anne-Laure ; Michel, Marie-Louise
Comparative Immunology, Microbiology and Infectious Diseases.  26 (2003)  5-6 - p. 357-372 , 2003
Link: https://doi.org/10.1016/..
 
?
9

The fully synthetic MAG-Tn3 therapeutic vaccine containing ..:

Laubreton, Daphné ; Bay, Sylvie ; Sedlik, Christine...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00262-016-1802-0.  , 2016
Link: https://hal-pasteur.arch..
 
?
10

The fully synthetic MAG-Tn3 therapeutic vaccine containing ..:

Laubreton, Daphné ; Bay, Sylvie ; Sedlik, Christine...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00262-016-1802-0.  , 2016
Link: https://hal-pasteur.arch..
 
?
11

The fully synthetic MAG-Tn3 therapeutic vaccine containing ..:

Laubreton, Daphné ; Bay, Sylvie ; Sedlik, Christine...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00262-016-1802-0.  , 2016
Link: https://hal-pasteur.arch..
 
?
12

The fully synthetic MAG-Tn3 therapeutic vaccine containing ..:

Laubreton, Daphné ; Bay, Sylvie ; Sedlik, Christine...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00262-016-1802-0.  , 2016
Link: https://pasteur.hal.scie..
 
?
13

The fully synthetic MAG-Tn3 therapeutic vaccine containing ..:

Laubreton, Daphné ; Bay, Sylvie ; Sedlik, Christine...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00262-016-1802-0.  , 2016
Link: https://hal-pasteur.arch..
 
?
14

MEK inhibition, alone or in combination with BRAF inhibitio..:

Vella, Laura J ; Pasam, Anupama ; Dimopoulos, Nektaria...
http://www.immunotherapyofcancer.org/content/1/S1/P93.  , 2013
Link: http://www.immunotherapy..
 
?
15

Tumor cells disseminate early, but immunosurveillance limit..:

Eyles, Jo ; Puaux, Anne-Laure ; Wang, Xiaojie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877955.  , 2010
Link: http://www.ncbi.nlm.nih...
 
1-15